Advanced Biomed (ADVB) Operating Expenses (2023 - 2026)

Advanced Biomed has reported Operating Expenses for 4 years, with the latest figure at $519836.0 in Q1 2026.

• Quarterly Operating Expenses fell 8.4% year-over-year to $519836.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 63.41% YoY) and the FY2025 annual result came in at $3.0 million, up 18.86% from the prior year.
• Operating Expenses advanced to $519836.0 in Q1 2026 per ADVB's latest filing, from $396642.0 in the prior quarter.
• Over five years, Operating Expenses peaked at $1.9 million in Q2 2025 and troughed at $280064.0 in Q4 2024.
• A 4-year average of $685520.4 and a median of $545710.5 in 2025 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses plunged 57.0% in 2024, then surged 176.16% in 2025.
• Over 4 years, Operating Expenses stood at $651302.0 in 2023, then slumped by 57.0% to $280064.0 in 2024, then jumped by 41.63% to $396642.0 in 2025, then soared by 31.06% to $519836.0 in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $519836.0, $396642.0, and $523914.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.